{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,13]],"date-time":"2026-11-13T22:21:06Z","timestamp":1794608466396,"version":"4.9.1"},"reference-count":39,"publisher":"Public Library of Science (PLoS)","issue":"2","license":[{"start":{"date-parts":[[2016,2,17]],"date-time":"2016-02-17T00:00:00Z","timestamp":1455667200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["www.plosntds.org"],"crossmark-restriction":false},"short-container-title":["PLoS Negl Trop Dis"],"DOI":"10.1371\/journal.pntd.0004464","type":"journal-article","created":{"date-parts":[[2016,2,17]],"date-time":"2016-02-17T18:43:42Z","timestamp":1455734622000},"page":"e0004464","update-policy":"https:\/\/doi.org\/10.1371\/journal.pntd.corrections_policy","source":"Crossref","is-referenced-by-count":24,"title":["Vaccination with Replication Deficient Adenovectors Encoding YF-17D Antigens Induces Long-Lasting Protection from Severe Yellow Fever Virus Infection in Mice"],"prefix":"10.1371","volume":"10","author":[{"given":"Maria R.","family":"Bassi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mads A. B.","family":"Larsen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael","family":"Kongsgaard","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael","family":"Rasmussen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S\u00f8ren","family":"Buus","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anette","family":"Stryhn","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Allan R.","family":"Thomsen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jan P.","family":"Christensen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"340","published-online":{"date-parts":[[2016,2,17]]},"reference":[{"key":"ref1","doi-asserted-by":"crossref","first-page":"553","DOI":"10.1586\/14760584.4.4.553","article-title":"Yellow fever vaccine","volume":"4","author":"TP Monath","year":"2005","journal-title":"Expert Rev Vaccines"},{"key":"ref2","doi-asserted-by":"crossref","first-page":"787","DOI":"10.1084\/jem.65.6.787","article-title":"The use of yellow fever virus modified by in vitro cultivation for human immunization","volume":"65","author":"M Theiler","year":"1937","journal-title":"J Exp Med"},{"key":"ref3","doi-asserted-by":"crossref","first-page":"767","DOI":"10.1084\/jem.65.6.767","article-title":"The effect of prolonged cultivation in vitro upon the pathogenicity of yellow fever virus","volume":"65","author":"M Theiler","year":"1937","journal-title":"J Exp Med"},{"key":"ref4","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1002\/(SICI)1096-9071(199810)56:2<159::AID-JMV10>3.0.CO;2-B","article-title":"Development of viremia and humoral and cellular parameters of immune activation after vaccination with yellow fever virus strain 17D: a model of human flavivirus infection","volume":"56","author":"B Reinhardt","year":"1998","journal-title":"J Med Virol"},{"key":"ref5","doi-asserted-by":"crossref","first-page":"308","DOI":"10.1016\/j.coi.2009.05.018","article-title":"Yellow fever vaccine\u2014how does it work and why do rare cases of serious adverse events take place?","volume":"21","author":"AD Barrett","year":"2009","journal-title":"Curr Opin Immunol"},{"key":"ref6","doi-asserted-by":"crossref","first-page":"512","DOI":"10.1093\/infdis\/169.3.512","article-title":"Analysis of a yellow fever virus isolated from a fatal case of vaccine-associated human encephalitis","volume":"169","author":"AD Jennings","year":"1994","journal-title":"J Infect Dis"},{"key":"ref7","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1016\/S0140-6736(01)05341-7","article-title":"Hepatitis and death following vaccination with 17D-204 yellow fever vaccine","volume":"358","author":"RC Chan","year":"2001","journal-title":"Lancet"},{"key":"ref8","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1016\/S0140-6736(01)05326-0","article-title":"Serious adverse events associated with yellow fever 17DD vaccine in Brazil: a report of two cases","volume":"358","author":"PF Vasconcelos","year":"2001","journal-title":"Lancet"},{"key":"ref9","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1016\/S0140-6736(01)05327-2","article-title":"Fever and multisystem organ failure associated with 17D-204 yellow fever vaccination: a report of four cases","volume":"358","author":"M Martin","year":"2001","journal-title":"Lancet"},{"key":"ref10","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1006\/viro.2001.1168","article-title":"Phenotypic and molecular analyses of yellow fever 17DD vaccine viruses associated with serious adverse events in Brazil","volume":"290","author":"R Galler","year":"2001","journal-title":"Virology"},{"key":"ref11","doi-asserted-by":"crossref","first-page":"e0003693","DOI":"10.1371\/journal.pntd.0003693","article-title":"A DNA vaccine against yellow fever virus: development and evaluation","volume":"9","author":"M Maciel Jr.","year":"2015","journal-title":"PLoS Negl Trop Dis"},{"key":"ref12","doi-asserted-by":"crossref","first-page":"6108","DOI":"10.1016\/j.vaccine.2008.09.007","article-title":"Comparison of multiple vaccine vectors in a single heterologous prime-boost trial","volume":"26","author":"B Barefoot","year":"2008","journal-title":"Vaccine"},{"key":"ref13","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1038\/415331a","article-title":"Replication-incompetent adenoviral vaccine vector elicits effective anti-immunodeficiency-virus immunity","volume":"415","author":"JW Shiver","year":"2002","journal-title":"Nature"},{"key":"ref14","doi-asserted-by":"crossref","first-page":"3339","DOI":"10.4049\/jimmunol.180.5.3339","article-title":"MHC class II-associated invariant chain linkage of antigen dramatically improves cell-mediated immunity induced by adenovirus vaccines","volume":"180","author":"PJ Holst","year":"2008","journal-title":"J Immunol"},{"key":"ref15","doi-asserted-by":"crossref","first-page":"7881","DOI":"10.1016\/j.vaccine.2010.09.079","article-title":"Comparison of T cell immune responses induced by vectored HIV vaccines in non-human primates and humans","volume":"28","author":"AJ Bett","year":"2010","journal-title":"Vaccine"},{"key":"ref16","doi-asserted-by":"crossref","first-page":"2355","DOI":"10.4049\/jimmunol.1001877","article-title":"Enhanced and sustained CD8+ T cell responses with an adenoviral vector-based hepatitis C virus vaccine encoding NS3 linked to the MHC class II chaperone protein invariant chain","volume":"186","author":"M Mikkelsen","year":"2011","journal-title":"J Immunol"},{"key":"ref17","doi-asserted-by":"crossref","first-page":"681","DOI":"10.1038\/nature01876","article-title":"Accelerated vaccination for Ebola virus haemorrhagic fever in non-human primates","volume":"424","author":"NJ Sullivan","year":"2003","journal-title":"Nature"},{"key":"ref18","doi-asserted-by":"crossref","first-page":"1126","DOI":"10.1038\/nm.3702","article-title":"Chimpanzee adenovirus vaccine generates acute and durable protective immunity against ebolavirus challenge","volume":"20","author":"DA Stanley","year":"2014","journal-title":"Nat Med"},{"key":"ref19","doi-asserted-by":"crossref","first-page":"115ra1","DOI":"10.1126\/scitranslmed.3003155","article-title":"Novel adenovirus-based vaccines induce broad and sustained T cell responses to HCV in man","volume":"4","author":"E Barnes","year":"2012","journal-title":"Sci Transl Med"},{"key":"ref20","doi-asserted-by":"crossref","first-page":"4152","DOI":"10.4049\/jimmunol.1301290","article-title":"Adenovirus-based vaccine against Listeria monocytogenes: extending the concept of invariant chain linkage","volume":"191","author":"S Jensen","year":"2013","journal-title":"J Immunol"},{"key":"ref21","doi-asserted-by":"crossref","first-page":"5191","DOI":"10.1016\/j.vaccine.2012.05.048","article-title":"Malaria vaccines: focus on adenovirus based vectors","volume":"30","author":"NJ Schuldt","year":"2012","journal-title":"Vaccine"},{"key":"ref22","doi-asserted-by":"crossref","first-page":"1141","DOI":"10.4049\/jimmunol.1402605","article-title":"CD8+ T cells complement antibodies in protecting against yellow fever virus","volume":"194","author":"MR Bassi","year":"2015","journal-title":"J Immunol"},{"key":"ref23","doi-asserted-by":"crossref","first-page":"6114","DOI":"10.4049\/jimmunol.163.11.6114","article-title":"Compromised virus control and augmented perforin-mediated immunopathology in IFN-gamma-deficient mice infected with lymphocytic choriomeningitis virus","volume":"163","author":"A Nansen","year":"1999","journal-title":"J Immunol"},{"issue":"Pt A","key":"ref24","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1016\/S0091-679X(08)60603-2","article-title":"Use of recombinant adenovirus for metabolic engineering of mammalian cells","volume":"43","author":"TC Becker","year":"1994","journal-title":"Methods Cell Biol"},{"key":"ref25","first-page":"239","article-title":"Monoclonal antibodies for the prevention of graft-versus-host disease and marrow graft rejection. The depletion of T cell subsets in vitro and in vivo","volume":"42","author":"S Cobbold","year":"1986","journal-title":"Transplantation"},{"key":"ref26","doi-asserted-by":"crossref","first-page":"548","DOI":"10.1038\/312548a0","article-title":"Therapy with monoclonal antibodies by elimination of T-cell subsets in vivo","volume":"312","author":"SP Cobbold","year":"1984","journal-title":"Nature"},{"key":"ref27","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1006\/viro.2002.1432","article-title":"Yellow fever virus 17D envelope and NS3 proteins are major targets of the antiviral T cell response in mice","volume":"296","author":"RG van der Most","year":"2002","journal-title":"Virology"},{"key":"ref28","doi-asserted-by":"crossref","first-page":"1708","DOI":"10.1099\/vir.0.82727-0","article-title":"Rapid and sustained CD4(+) T-cell-independent immunity from adenovirus-encoded vaccine antigens","volume":"88","author":"PJ Holst","year":"2007","journal-title":"J Gen Virol"},{"key":"ref29","doi-asserted-by":"crossref","first-page":"852","DOI":"10.1038\/nature01441","article-title":"CD4+ T cells are required for secondary expansion and memory in CD8+ T lymphocytes","volume":"421","author":"EM Janssen","year":"2003","journal-title":"Nature"},{"key":"ref30","doi-asserted-by":"crossref","first-page":"927","DOI":"10.1038\/ni1105","article-title":"CD4+ T cells are required for the maintenance, not programming, of memory CD8+ T cells after acute infection","volume":"5","author":"JC Sun","year":"2004","journal-title":"Nat Immunol"},{"key":"ref31","doi-asserted-by":"crossref","first-page":"8073","DOI":"10.1016\/j.vaccine.2010.10.015","article-title":"Is it time for a new yellow fever vaccine?","volume":"28","author":"EB Hayes","year":"2010","journal-title":"Vaccine"},{"key":"ref32","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1016\/j.jviromet.2008.03.002","article-title":"Pressure-inactivated yellow fever 17DD virus: implications for vaccine development","volume":"150","author":"LP Gaspar","year":"2008","journal-title":"J Virol Methods"},{"key":"ref33","doi-asserted-by":"crossref","first-page":"3827","DOI":"10.1016\/j.vaccine.2010.03.023","article-title":"Inactivated yellow fever 17D vaccine: development and nonclinical safety, immunogenicity and protective activity","volume":"28","author":"TP Monath","year":"2010","journal-title":"Vaccine"},{"key":"ref34","doi-asserted-by":"crossref","first-page":"1326","DOI":"10.1056\/NEJMoa1009303","article-title":"An inactivated cell-culture vaccine against yellow fever","volume":"364","author":"TP Monath","year":"2011","journal-title":"N Engl J Med"},{"key":"ref35","doi-asserted-by":"crossref","first-page":"1053","DOI":"10.1128\/CVI.00173-07","article-title":"Seroprevalence of neutralizing antibodies to adenovirus type 5 among children in India: implications for recombinant adenovirus-based vaccines","volume":"14","author":"MB Appaiahgari","year":"2007","journal-title":"Clin Vaccine Immunol"},{"key":"ref36","doi-asserted-by":"crossref","first-page":"e106240","DOI":"10.1371\/journal.pone.0106240","article-title":"Homologous boosting with adenoviral serotype 5 HIV vaccine (rAd5) vector can boost antibody responses despite preexisting vector-specific immunity in a randomized phase I clinical trial","volume":"9","author":"UN Sarwar","year":"2014","journal-title":"PLoS One"},{"key":"ref37","doi-asserted-by":"crossref","first-page":"e34884","DOI":"10.1371\/journal.pone.0034884","article-title":"Pre-existing vector immunity does not prevent replication deficient adenovirus from inducing efficient CD8 T-cell memory and recall responses","volume":"7","author":"MA Steffensen","year":"2012","journal-title":"PLoS One"},{"key":"ref38","article-title":"A Monovalent Chimpanzee Adenovirus Ebola Vaccine\u2014Preliminary Report","author":"T Rampling","year":"2015","journal-title":"N Engl J Med"},{"key":"ref39","doi-asserted-by":"crossref","first-page":"115ra2","DOI":"10.1126\/scitranslmed.3002925","article-title":"Vaccine vectors derived from a large collection of simian adenoviruses induce potent cellular immunity across multiple species","volume":"4","author":"S Colloca","year":"2012","journal-title":"Sci Transl Med"}],"container-title":["PLOS Neglected Tropical Diseases"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/dx.plos.org\/10.1371\/journal.pntd.0004464","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,8,16]],"date-time":"2023-08-16T22:28:56Z","timestamp":1692224936000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pntd.0004464"}},"subtitle":[],"editor":[{"given":"Scott F.","family":"Michael","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"editor"}]}],"short-title":[],"issued":{"date-parts":[[2016,2,17]]},"references-count":39,"journal-issue":{"issue":"2","published-online":{"date-parts":[[2016,2,17]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.pntd.0004464","relation":{"has-part":[{"id-type":"doi","id":"https:\/\/doi.org\/10.1371\/journal.pntd.0004464.g001","asserted-by":"subject"},{"id-type":"doi","id":"https:\/\/doi.org\/10.1371\/journal.pntd.0004464.g002","asserted-by":"subject"},{"id-type":"doi","id":"https:\/\/doi.org\/10.1371\/journal.pntd.0004464.g003","asserted-by":"subject"},{"id-type":"doi","id":"https:\/\/doi.org\/10.1371\/journal.pntd.0004464.g004","asserted-by":"subject"},{"id-type":"doi","id":"https:\/\/doi.org\/10.1371\/journal.pntd.0004464.g005","asserted-by":"subject"},{"id-type":"doi","id":"https:\/\/doi.org\/10.1371\/journal.pntd.0004464.g006","asserted-by":"subject"},{"id-type":"doi","id":"https:\/\/doi.org\/10.1371\/journal.pntd.0004464.g007","asserted-by":"subject"},{"id-type":"doi","id":"https:\/\/doi.org\/10.1371\/journal.pntd.0004464.g008","asserted-by":"subject"},{"id-type":"doi","id":"https:\/\/doi.org\/10.1371\/journal.pntd.0004464.s001","asserted-by":"subject"}]},"ISSN":["1935-2735"],"issn-type":[{"value":"1935-2735","type":"electronic"}],"subject":[],"published":{"date-parts":[[2016,2,17]]}}}